Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Platelet-rich plasma, microneedling with minoxidil, and topical finasteride are promising treatments for hair loss.

Finasteride and DEHP exposure during development can change reproductive markers in rats.

Six months of treatment improved PCOS symptoms and reduced AMH levels.

Progesterone and its metabolites affect myelin protein expression differently in male and female rat Schwann cells.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Neurosteroids help protect fetal brains from asphyxia damage.

Clascoterone may be an effective topical treatment for hair loss.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Oral contraceptives can affect skin and hair, improve acne, but may cause pigmentation, dermatitis, and other conditions.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Prostaglandin D2 increases testosterone levels in skin cells through reactive oxygen species, not enzymes, which could lead to new hair loss treatments.

Finasteride, a drug used for anti-hyperplasia, can be effectively delivered in the form of matrix tablets.

Androgens may improve pig reproduction by enhancing ovulation and litter size.

LMWP-PDGFA shows promise for improving hair health and treating hair loss with fewer side effects.

Hair loss in women can be treated with hormone therapy.

High levels of certain fats in rapeseed oil can reduce the skin's ability to produce prostaglandin E2 and cause hair loss and skin issues in rats.

Treat hirsutism in premenopausal women with oral contraceptives and consider additional treatments if needed.

A 77-year-old woman with hair loss had high testosterone and 17OH-progesterone levels, but no significant findings on imaging.

The new gel formula could improve the delivery of a hair loss treatment through the skin and might be an alternative to taking it by mouth.

COCs can improve acne but may cause skin issues like cholasma; high estrogen is advised for hair loss concerns.